These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2137888)

  • 1. Increase in plasma 5 alpha-androstane-3 alpha,17 beta-diol glucuronide as a marker of peripheral androgen action in hirsutism: a side-effect induced by cyclosporine A.
    Vexiau P; Fiet J; Boudou P; Villette JM; Feutren G; Hardy N; Julien R; Dreux C; Bach JF; Cathelineau G
    J Steroid Biochem; 1990 Jan; 35(1):133-7. PubMed ID: 2137888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of 5-androstene-3 beta,17 beta-diol sulphate, 5 alpha-androstane-3 alpha, 17beta-diol sulphate and glucuronide, in late onset 21-hydroxylase deficiency.
    Montalto J; Funder JW; Yong AB; Whorwood CB; Connelly JF
    J Steroid Biochem Mol Biol; 1990 Nov; 37(4):593-8. PubMed ID: 2177625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum 5-androstene-3 beta,17 beta-diol sulphate and 5 alpha-androstane-3 alpha,17 beta-diol sulphate in hirsute females with polycystic ovarian disease.
    Montalto J; Funder JW; Yong AB; Davies HE; Connelly JF
    J Steroid Biochem; 1990 Jun; 36(1-2):67-74. PubMed ID: 2362450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma C19 steroid sulphate levels and indices of androgen bioavailability in female pattern androgenic alopecia.
    Montalto J; Whorwood CB; Funder JW; Yong AB; Callan A; Davies HE; Connelly JF
    Clin Endocrinol (Oxf); 1990 Jan; 32(1):1-12. PubMed ID: 2139595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is 3 alpha, 17 beta-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
    Vogt C; Dericks-Tan JS; Kuhl H; Taubert HD
    Gynecol Endocrinol; 1992 Jun; 6(2):85-90. PubMed ID: 1386956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of 5 alpha-reductase activity in hirsute women: comparison of serum androstanediol glucuronide with urinary androsterone and aetiocholanolone excretion.
    Gilad S; Chayen R; Tordjman K; Kisch E; Stern N
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):459-64. PubMed ID: 8187312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of serum 3 alpha-androstanediol glucuronide with acne and chest hair density in men.
    Lookingbill DP; Egan N; Santen RJ; Demers LM
    J Clin Endocrinol Metab; 1988 Nov; 67(5):986-91. PubMed ID: 2972739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
    Lobo RA; Goebelsmann U; Horton R
    J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Female androgenic alopecia. The 3 alpha,17 beta-androstanediol glucuronide/sex hormone binding globulin ratio as a possible marker for female pattern baldness.
    De Villez RL; Dunn J
    Arch Dermatol; 1986 Sep; 122(9):1011-5. PubMed ID: 2943232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of short- and long-term dexamethasone on 3 alpha-androstanediol glucuronide in hirsute women.
    Meikle AW; Odell WD
    Fertil Steril; 1986 Aug; 46(2):227-31. PubMed ID: 3015694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects.
    Zimmerman Y; Foidart JM; Pintiaux A; Minon JM; Fauser BC; Cobey K; Coelingh Bennink HJ
    Contraception; 2015 Feb; 91(2):127-33. PubMed ID: 25604900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is hirsutism an evolving syndrome?
    Toscano V; Adamo MV; Caiola S; Foli S; Petrangeli E; Casilli D; Sciarra F
    J Endocrinol; 1983 Jun; 97(3):379-87. PubMed ID: 6223108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum C-19 steroid sulphates in females with clinical hyperandrogenism.
    Montalo J; Funder JW; Yong AB; Callan A; Davies HE; Connelly JF
    J Steroid Biochem; 1989; 34(1-6):531-4. PubMed ID: 2533951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels.
    Pang S; Wang M; Jeffries S; Riddick L; Clark A; Estrada E
    J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of plasma 5 alpha-androstane-3 alpha, 17 beta-diol in the hirsute woman. A critical study of the biological diagnosis of hyperandrogenism].
    Heim J; Massart C
    Nouv Presse Med; 1982 Nov; 11(47):3495-9. PubMed ID: 6218480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two different pathogenetic mechanisms may play a role in acne and in hirsutism.
    Toscano V; Balducci R; Bianchi P; Guglielmi R; Mangiantini A; Rossi FG; Colonna LM; Sciarra F
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):551-6. PubMed ID: 8252744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.
    Horton R; Hawks D; Lobo R
    J Clin Invest; 1982 May; 69(5):1203-6. PubMed ID: 7068855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum androsterone conjugates differentiate between acne and hirsutism in hyperandrogenic women.
    Carmina E; Stanczyk FZ; Matteri RK; Lobo RA
    Fertil Steril; 1991 May; 55(5):872-6. PubMed ID: 1827073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemfibrozil treatment is associated with elevated adrenal androgen, androstanediol glucuronide and cortisol levels in dyslipidemic men.
    Hautanen A; Mänttäri M; Manninen V; Adlercreutz H
    J Steroid Biochem Mol Biol; 1994 Dec; 51(5-6):307-13. PubMed ID: 7826893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased free testosterone but normal 5 alpha-reduced testosterone metabolites in obese premenopausal women.
    Giagulli VA; De Pergola G; Giorgino F; Cignarelli M; Abbaticchio G; Vermeulen A; Giorgino R
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):553-8. PubMed ID: 1424180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.